Role of Interleukin-6 in Depressive Disorder
- PMID: 32235786
- PMCID: PMC7139933
- DOI: 10.3390/ijms21062194
Role of Interleukin-6 in Depressive Disorder
Abstract
Major depressive disorder (MDD), which is a leading psychiatric illness across the world, severely affects quality of life and causes an increased incidence of suicide. Evidence from animal as well as clinical studies have indicated that increased peripheral or central cytokine interleukin-6 (IL-6) levels play an important role in stress reaction and depressive disorder, especially physical disorders comorbid with depression. Increased release of IL-6 in MDD has been found to be a factor associated with MDD prognosis and therapeutic response, and may affect a wide range of depressive symptomatology. However, study results of the IL6 genetic effects in MDD are controversial. Increased IL-6 activity may cause depression through activation of hypothalamic-pituitary-adrenal axis or influence of the neurotransmitter metabolism. The important role of neuroinflammation in MDD pathogenesis has created a new perspective that the combining of blood IL-6 and other depression-related cytokine levels may help to classify MDD biological subtypes, which may allow physicians to identify the optimal treatment for MDD patients. To modulate the IL-6 activity by IL-6-related agents, current antidepressive agents, herb medication, pre-/probiotics or non-pharmacological interventions may hold great promise for the MDD patients with inflammatory features.
Keywords: antidepressant; interleukin-6; major depressive disorder; polymorphism; stress.
Conflict of interest statement
S.-J.T. has received support from the Taiwan Ministry of Science and Technology, and from the Taipei Veterans General Hospital. There is no commercial or financial involvement that might present an appearance of a conflict of interest in connection with the submitted article. E.Y.-C.T. and A.C.Y declare no conflict of interest.
Figures
Similar articles
-
An altered peripheral IL6 response in major depressive disorder.Neurobiol Dis. 2016 May;89:46-54. doi: 10.1016/j.nbd.2016.01.015. Epub 2016 Jan 22. Neurobiol Dis. 2016. PMID: 26804030 Free PMC article.
-
Neural basis of major depressive disorder: Beyond monoamine hypothesis.Psychiatry Clin Neurosci. 2018 Jan;72(1):3-12. doi: 10.1111/pcn.12604. Epub 2017 Oct 19. Psychiatry Clin Neurosci. 2018. PMID: 28926161 Review.
-
Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder.Biol Psychiatry. 2006 Apr 1;59(7):667-71. doi: 10.1016/j.biopsych.2005.08.001. Epub 2005 Sep 30. Biol Psychiatry. 2006. PMID: 16199015
-
Physical Exercise and Neuroinflammation in Major Depressive Disorder.Mol Neurobiol. 2019 Dec;56(12):8323-8335. doi: 10.1007/s12035-019-01670-1. Epub 2019 Jun 21. Mol Neurobiol. 2019. PMID: 31228000 Review.
-
Investigating the Role of TNF-Alpha through Blood-Brain Barrier Integrity in Stress-Induced Depression.Neuropsychopharmacol Hung. 2024 Dec;26(4):197-203. Neuropsychopharmacol Hung. 2024. PMID: 39760673 English.
Cited by
-
Combined serum IL-6, C-reactive protein, and cortisol may distinguish patients with anhedonia in major depressive disorder.Front Mol Neurosci. 2022 Aug 24;15:935031. doi: 10.3389/fnmol.2022.935031. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36090246 Free PMC article.
-
Kynurenic acid as a biochemical factor underlying the association between Western-style diet and depression: A cross-sectional study.Front Nutr. 2022 Oct 10;9:945538. doi: 10.3389/fnut.2022.945538. eCollection 2022. Front Nutr. 2022. PMID: 36299996 Free PMC article.
-
Mechanism of Chaihu Longgu oyster adjusted decoction for the treatment of depression based on network pharmacology and molecular docking technology.Ann Transl Med. 2023 Feb 28;11(4):172. doi: 10.21037/atm-23-236. Epub 2023 Feb 22. Ann Transl Med. 2023. PMID: 36923088 Free PMC article.
-
Inflamed Mind: Multiple Genetic Variants of IL6 Influence Suicide Risk Phenotypes in Interaction With Early and Recent Adversities in a Linkage Disequilibrium-Based Clumping Analysis.Front Psychiatry. 2021 Oct 29;12:746206. doi: 10.3389/fpsyt.2021.746206. eCollection 2021. Front Psychiatry. 2021. PMID: 34777050 Free PMC article.
-
Lifestyle factors and BMI attenuate relationships between biomarkers of inflammation and depressive symptoms and well-being: A cross-sectional study.Brain Behav Immun Health. 2024 Mar 18;37:100759. doi: 10.1016/j.bbih.2024.100759. eCollection 2024 May. Brain Behav Immun Health. 2024. PMID: 38560580 Free PMC article.
References
-
- Dunn A.J., Wang J., Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv. Exp. Med. Biol. 1999;461:117–127. - PubMed
-
- Licinio J., Wong M.L. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry. 1999;4:317–327. doi: 10.1038/sj.mp.4000586. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical